FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA
Applications are based on data from the DEVOTE study, which demonstrate the potential for the investigational higher dose ...
bovnews22 分钟
Why Is Netflix Inc (NFLX) Stock Surpassing 8.24% from Its 50-Day SMA?
Netflix Inc (NFLX) stock saw a modest uptick, ending the day at $953.99 which represents a slight increase of $84.31 or 9.69% from the prior close of $869.68. The stock opened at $998.03 and touched a ...
Biogen Inc.: FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA
Applications are based on data from the DEVOTE study, which demonstrate the potential for the investigational higher dose regimen of nusinersen to advance the treatment of SMA CAMBRIDGE, Mass., Jan. 2 ...
Le Lézard27 分钟
MSTROtm Secures $1.5 Million in Seed Funding for AI Solution to Spark Human Innovation
MSTRO, a privately owned company, redefining human potential by revolutionizing how we reason through data, is proud to announce the successful completion of a $1.5 million seed funding round. This ...
US Dollar flat after small recovery staged on Wednesday
On the downside, the first area to watch is 107.80-107.90, which held this week’s correction. Further down, the convergence ...
Le Lézard32 分钟
VANTIS VASCULAR ANNOUNCES SUPERIOR CLINICAL PERFORMANCE OF THE CROSSFAST ADVANCED DELIVERY ...
Vantis Vascular, Inc., a pioneering medical technology company founded by physicians with a passion to revolutionize vascular interventions, today announced the first commercial use of its CrossFAST ...